Looking Into Matinas BioPharma Hldgs's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Matinas BioPharma Holdings (NYSE:MTNB) has seen a 6.98% increase in its short percent of float, now at 0.92% of all regular shares. This indicates a rise in bearish sentiment, although it remains below the peer group average of 4.90%. Traders should be aware of the increased short interest.
July 15, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Matinas BioPharma Holdings has experienced a 6.98% increase in short interest, now at 0.92% of its float. This rise in short interest suggests growing bearish sentiment among traders, although it remains below the peer group average of 4.90%.
The increase in short interest indicates that more traders are betting against the stock, which could lead to downward pressure on the stock price in the short term. However, the short interest is still below the peer average, which may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100